name:-0.023149013519287
name:-0.010154962539673
name:-0.017023086547852
Parks; Daniel Patent Filings

Parks; Daniel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Parks; Daniel.The latest application filed is for "compounds, compositions, and methods for modulating cftr".

Company Profile
14.9.17
  • Parks; Daniel - Pepperell MA
  • Parks; Daniel - Los Angeles CA
  • Parks; Daniel - Downingtown PA
  • Parks; Daniel - Downington PA US
  • Parks; Daniel - Glendale AZ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Compounds, Compositions, And Methods For Modulating Cftr
App 20220227739 - Munoz; Benito ;   et al.
2022-07-21
Compounds, compositions, and methods for modulating CFTR
Grant 11,248,010 - Munoz , et al. February 15, 2
2022-02-15
Compounds, Compositions, And Methods For Increasing Cftr Activity
App 20210369749 - Parks; Daniel ;   et al.
2021-12-02
Compounds, compositions, and methods for modulating CFTR
Grant 11,136,313 - Munoz , et al. October 5, 2
2021-10-05
Proteasome Activity Enhancing Compounds
App 20210115057 - Cullen; Matthew ;   et al.
2021-04-22
Compounds, Compositions, And Methods For Modulating Cftr
App 20210061823 - Munoz; Benito ;   et al.
2021-03-04
Compounds, compositions, and methods for increasing CFTR activity
Grant 10,899,751 - Parks , et al. January 26, 2
2021-01-26
Compounds, Compositions, And Methods For Modulating Cftr
App 20200385365 - Munoz; Benito ;   et al.
2020-12-10
Compounds, compositions, and methods for modulating CFTR
Grant 10,662,207 - Munoz , et al.
2020-05-26
Augmented reality positioning and tracking system and method
Grant 10,607,385 - Parks , et al.
2020-03-31
4-sulfonylaminocarbonylquinoline Derivatives For Increasing Cftr Activity
App 20200055844 - PARKS; Daniel ;   et al.
2020-02-20
Compounds, compositions, and methods for modulating CFTR
Grant 10,550,106 - Munoz , et al. Fe
2020-02-04
Compounds, Compositions, And Methods For Increasing Cftr Activity
App 20200010461 - Parks; Daniel ;   et al.
2020-01-09
N-phenyl-2-(3-phenyl-6-oxo-1,6-dihydropyridazin-1-yl)acetamide Derivatives For Treating Cystic Fibrosis
App 20190256474 - Parks; Daniel ;   et al.
2019-08-22
Compounds, Compositions, And Methods For Increasing Cftr Activity
App 20190248779 - Parks; Daniel ;   et al.
2019-08-15
Compounds, Compositions, And Methods For Increasing Cftr Activity
App 20190248765 - Parks; Daniel ;   et al.
2019-08-15
Augmented Reality Positioning And Tracking System And Method
App 20190164325 - PARKS; Daniel ;   et al.
2019-05-30
Compounds, Compositions, And Methods For Modulating Cftr
App 20190153000 - Munoz; Benito ;   et al.
2019-05-23
Compounds, Compositions, And Methods For Modulating Cftr
App 20180291006 - Munoz; Benito ;   et al.
2018-10-11
Substituted Aza-bicyclic Imidazole Derivatives Useful As Trpm8 Receptor Modulators
App 20140155395 - Player; Mark R. ;   et al.
2014-06-05
Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators
Grant 8,680,098 - Player , et al. March 25, 2
2014-03-25
Substituted Benzimdazole Derivatives Useful As Trpm8 Receptor Modulators
App 20120202856 - PLAYER; Mark R. ;   et al.
2012-08-09
Substituted Aza-bicyclic Imidazole Derivatives Useful As Trpm8 Receptor Modulators
App 20110218197 - PLAYER; Mark R. ;   et al.
2011-09-08
System and method for web access to financial data
Grant 7,647,257 - Allen , et al. January 12, 2
2010-01-12
System and method for web access to financial data
App 20040225603 - Allen, Laurie ;   et al.
2004-11-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed